(Q39830867)
Statements
1 reference
Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials (English)
1 reference
Philip J Rosenfeld
1 reference
Howard Shapiro
1 reference
Lisa Tuomi
1 reference
Mary Webster
1 reference
Julee Elledge
1 reference
Barbara Blodi
1 reference
MARINA and ANCHOR Study Groups
1 reference
1 March 2011
1 reference
1 reference
118
1 reference
3
1 reference
523-530
1 reference
Identifiers
1 reference
1 reference